EPISODE · Jul 11, 2025 · 33 MIN
Conversations with Raven S2EP6
from No Apologies · host Raven Keefer
Update on the previous episode with the current data. Also, transportation and international information for the regions.Mahe Ohna ✌️ Favour ALL [email protected] NIPAH exercise link:https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/Ravens's Music Videos Playlist:https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=sharedRaven's Music on YT (all five LPs vailable on almost all music streaming platforms):https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=sharedRaven's Laugh Podcastshttps://www.spreaker.com/podcast/laugh-podcasts--5686542Buy me a coffee to keep my technology and service active? https://ko-fi.com/ravenkeeferFrom India NIH:The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)
What this episode covers
Update on the previous episode with the current data. Also, transportation and international information for the regions.Mahe Ohna ✌️ Favour ALL [email protected] NIPAH exercise link:https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/Ravens's Music Videos Playlist:https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=sharedRaven's Music on YT (all five LPs vailable on almost all music streaming platforms):https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=sharedRaven's Laugh Podcastshttps://www.spreaker.com/podcast/laugh-podcasts--5686542Buy me a coffee to keep my technology and service active? https://ko-fi.com/ravenkeeferFrom India NIH:The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)
NOW PLAYING
Conversations with Raven S2EP6
No transcript for this episode yet
Similar Episodes
May 3, 2026 ·119m
Apr 20, 2026 ·57m
Apr 13, 2026 ·59m
Apr 6, 2026 ·67m